Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Stage III melanoma in the axilla: patterns of regional recurrence after surgery with and without adjuvant radiation therapy.

Pinkham MB, Foote MC, Burmeister E, Thomas J, Meakin J, Smithers BM, Burmeister BH.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):702-8. doi: 10.1016/j.ijrobp.2013.03.019.

PMID:
23773393
2.

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):467-74.

PMID:
10661355
3.

Adjuvant irradiation for axillary metastases from malignant melanoma.

Ballo MT, Strom EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, Lee JE, Gershenwald JE, Ross MI.

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):964-72.

PMID:
11958890
4.

Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?

Moncrieff MD, Martin R, O'Brien CJ, Shannon KF, Clark JR, Gao K, McCarthy WM, Thompson JF.

Ann Surg Oncol. 2008 Nov;15(11):3022-7. doi: 10.1245/s10434-008-0087-8. Epub 2008 Oct 30.

PMID:
18958539
5.

The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.

Agrawal S, Kane JM 3rd, Guadagnolo BA, Kraybill WG, Ballo MT.

Cancer. 2009 Dec 15;115(24):5836-44. doi: 10.1002/cncr.24627.

6.

Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?

Barbour S, Mark Smithers B, Allan C, Bayley G, Thomas J, Foote M, Burmeister B, Barbour AP.

Ann Surg Oncol. 2015 Nov;22(12):4052-9. doi: 10.1245/s10434-014-4356-4. Epub 2015 Jan 13.

PMID:
25582744
7.

Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.

Stevens G, Thompson JF, Firth I, O'Brien CJ, McCarthy WH, Quinn MJ.

Cancer. 2000 Jan 1;88(1):88-94.

PMID:
10618610
8.

A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.

Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, Camacho LH, Hwu P, Ross MI.

Ann Surg Oncol. 2004 Dec;11(12):1079-84.

PMID:
15576833
9.

Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.

Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di Iulio J, Smithers BM, Hong A, Shannon K, Scolyer RA, Carruthers S, Coventry BJ, Babington S, Duprat J, Hoekstra HJ, Thompson JF.

Lancet Oncol. 2012 Jun;13(6):589-97. doi: 10.1016/S1470-2045(12)70138-9. Epub 2012 May 9.

PMID:
22575589
10.

Combined-modality therapy for patients with regional nodal metastases from melanoma.

Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, Hwu P, Zagars GK.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):106-13. Epub 2005 Sep 22.

PMID:
16182463
11.
12.

Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.

Beadle BM, Guadagnolo BA, Ballo MT, Lee JE, Gershenwald JE, Cormier JN, Mansfield PF, Ross MI, Zagars GK.

Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1376-82. doi: 10.1016/j.ijrobp.2008.06.1910. Epub 2008 Sep 5.

PMID:
18774657
13.

Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Dar AR, Venkatesan VM, Stitt L, Radwan JS.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):551-9.

PMID:
9231679
14.

An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection.

Foote M, Burmeister B, Dwyer P, Burmeister E, Lambie D, Allan C, Barbour A, Bayley G, Pullar A, Meakin J, Thomas J, Smithers M.

Melanoma Res. 2012 Jun;22(3):257-62. doi: 10.1097/CMR.0b013e3283531335.

PMID:
22547205
15.

Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate?

Gojkovič-Horvat A, Jančar B, Blas M, Zumer B, Karner K, Hočevar M, Strojan P.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):310-6. doi: 10.1016/j.ijrobp.2011.06.1979. Epub 2011 Oct 27.

PMID:
22035662
16.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Venkatesan V, Dar AR, Stitt L.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):541-50.

PMID:
9231678
17.

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.

Fisher BJ, Perera FE, Cooke AL, Opeitum A, Stitt L.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):117-23.

PMID:
9747828
18.

Patterns of recurrence in patients with melanoma after radical lymph node dissection.

Nathansohn N, Schachter J, Gutman H.

Arch Surg. 2005 Dec;140(12):1172-7.

PMID:
16365238
19.

Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity.

Burmeister BH, Smithers BM, Davis S, Spry N, Johnson C, Krawitz H, Baumann KC.

ANZ J Surg. 2002 May;72(5):344-8.

PMID:
12028092
20.

Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.

Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, Sauer R.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):607-18.

PMID:
10348291

Supplemental Content

Support Center